Security key
126650100
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,272,949,774
- Total 13F shares
- 855,048,114
- Share change
- +1,611,130
- Total reported value
- $53,133,760,227
- Put/Call ratio
- 132%
- Price per share
- $62.21
- Number of holders
- 1,540
- Value change
- +$40,291,614
- Number of buys
- 721
- Number of sells
- 803
Report period
Q1 2018
Institutions
1,540
Top holders
10
CVS full security history
Newer quarter: Q2 2018
Previous quarter: Q4 2017
CVS HEALTH Corp SEC filings
CVS HEALTH Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 126650100
Recent filing periods:
Top shareholders of CVS - CVS HEALTH Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
78,578,807
|
$5,696,964,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.3%
|
66,996,510
|
$4,857,249,000 | — | 31 Dec 2017 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
42,939,809
|
$3,113,153,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
2.7%
|
34,296,491
|
$2,486,496,000 | — | 31 Dec 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.8%
|
22,566,156
|
$1,636,047,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
15,643,136
|
$1,134,128,000 | — | 31 Dec 2017 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
1.2%
|
15,514,373
|
$1,124,793,000 | — | 31 Dec 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
15,086,080
|
$1,093,741,000 | — | 31 Dec 2017 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
1.1%
|
14,488,548
|
$1,050,420,000 | — | 31 Dec 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.97%
|
12,336,332
|
$894,384,000 | — | 31 Dec 2017 | |
| Veritas Asset Management LLP |
13F
|
Company |
0.92%
|
11,683,524
|
$847,055,000 | — | 31 Dec 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.85%
|
10,870,902
|
$788,188,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
10,868,331
|
$786,322,000 | — | 31 Dec 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.84%
|
10,705,489
|
$776,147,000 | — | 31 Dec 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.83%
|
10,557,347
|
$765,174,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0.8%
|
10,227,921
|
$741,524,000 | — | 31 Dec 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.76%
|
9,654,686
|
$699,966,000 | — | 31 Dec 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.72%
|
9,219,365
|
$668,688,000 | — | 31 Dec 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.71%
|
9,088,287
|
$658,900,000 | — | 31 Dec 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.71%
|
9,013,751
|
$653,498,000 | — | 31 Dec 2017 | |
| Vulcan Value Partners, LLC |
13F
|
Company |
0.69%
|
8,839,878
|
$640,892,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.66%
|
8,339,457
|
$604,611,000 | — | 31 Dec 2017 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.61%
|
7,792,221
|
$564,936,000 | — | 31 Dec 2017 | |
| Boston Partners |
13F
|
Company |
0.61%
|
7,774,165
|
$563,627,000 | — | 31 Dec 2017 | |
| HARRIS ASSOCIATES L P |
13F
|
Company |
0.61%
|
7,757,853
|
$562,445,000 | — | 31 Dec 2017 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
0.57%
|
7,213,130
|
$522,952,000 | — | 31 Dec 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.56%
|
7,081,461
|
$513,406,000 | — | 31 Dec 2017 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.54%
|
6,871,164
|
$498,159,000 | — | 31 Dec 2017 | |
| GLENVIEW CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
6,821,631
|
$494,568,000 | — | 31 Dec 2017 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.53%
|
6,720,579
|
$487,242,000 | — | 31 Dec 2017 | |
| Capital World Investors |
13F
|
Company |
0.51%
|
6,500,004
|
$471,250,000 | — | 31 Dec 2017 | |
| APG Asset Management N.V. |
13F
|
Company |
0.47%
|
6,023,527
|
$363,679,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.47%
|
5,984,505
|
$433,876,000 | — | 31 Dec 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.47%
|
5,953,663
|
$431,666,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.46%
|
5,862,623
|
$425,040,000 | — | 31 Dec 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.46%
|
5,813,488
|
$421,479,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.42%
|
5,319,189
|
$385,633,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0.41%
|
5,188,196
|
$376,144,000 | — | 31 Dec 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.38%
|
4,818,244
|
$349,322,000 | — | 31 Dec 2017 | |
| Capital Research Global Investors |
13F
|
Company |
0.35%
|
4,511,137
|
$327,057,000 | — | 31 Dec 2017 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.35%
|
4,399,187
|
$318,943,000 | — | 31 Dec 2017 | |
| Aberdeen Group plc |
13F
|
Company |
0.34%
|
4,377,683
|
$317,382,000 | — | 31 Dec 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
4,311,444
|
$312,580,000 | — | 31 Dec 2017 | |
| Sentry Investments Corp. |
13F
|
Company |
0.34%
|
4,296,700
|
$311,511,000 | — | 31 Dec 2017 | |
| Swiss National Bank |
13F
|
Company |
0.3%
|
3,801,310
|
$275,595,000 | — | 31 Dec 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.3%
|
3,755,871
|
$272,299,000 | — | 31 Dec 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.28%
|
3,618,574
|
$262,347,000 | — | 31 Dec 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.28%
|
3,584,649
|
$259,887,059 | — | 31 Dec 2017 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.27%
|
3,393,733
|
$246,046,000 | — | 31 Dec 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
3,383,550
|
$245,307,000 | — | 31 Dec 2017 |
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q1 2018
As of 31 Mar 2018,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,540 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
855,048,114 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BARROW HANLEY MEWHINNEY & STRAUSS LLC, PARNASSUS INVESTMENTS /CA, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/.
This page lists
1,541
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
1,590
Q1 2018 holders
1,540
Holder diff
-50
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.